Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEISB.L Regulatory News (EISB)

  • There is currently no data for EISB

Placing and year-end update

13 Jan 2022 07:00

RNS Number : 3332Y
East Imperial PLC
13 January 2022
Β 

Β 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, TO UNITED STATES NEWS WIRE SERVICES OR IN OR INTO, AUSTRALIA, CANADA, JAPAN, THE UNITED STATES OF AMERICA OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT, OTHER THAN PURSUANT TO AN APPLICABLE EXEMPTION

Β 

13 January 2022

East Imperial plc (the "Company")

Placing, year end update and PDMR dealing

Β 

East Imperial, the global purveyor of ultra-premium beverages, is pleased to announce the conditional placing of 32,398,899 shares at 10.5 pence per share (the "Placing"), raising gross proceeds of approximately Β£3.4 million to support the Company's intentions to accelerate its expansion.

Β 

The Company also provides a year end update and announces a 60% increase in 2021 revenues compared to the prior year, based on unaudited figures.

Β 

The Placing

Β 

East Imperial has executed placing letters with institutional and other investors and certain of the Company's directors, to place 32,398,899 shares ("Placing Shares") at 10.5 pence per share, raising gross proceeds of Β£3,401,884.40. The Placing was the result of demand for shares from a number of institutions including Aviva Investors, who subscribed for 9 million shares, taking their total beneficial shareholding in the Company to approximately 26.1 million, or 7.7 percent.

Β 

The Placing is conditional on Admission (defined below). Applications will be made to the Financial Conduct Authority ("FCA") for the Placing Shares to be admitted to the Standard Segment of the Official List of the FCA (the "Official List") and to London Stock Exchange plc (the "LSE") for the Placing Shares to be admitted to trading on the LSE's Main Market for listed securities ("Admission"). It is expected that Admission will become effective, and trading in the Placing Shares will commence, on or around 21 January 2022.

Β 

The Company intends to use the proceeds from the Placing to accelerate the expansion of the business, in particular across the US market, the key strategic priority for the Board.

Β 

Following admission of the Placing Shares, the Company's issued ordinary share capital will comprise 338,171,013 ordinary shares, none of which are held in treasury. Therefore, the total number of ordinary shares with voting rights in East Imperial following admission will be 338,171,013.

Β 

The above figure of 338,171,013 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

Β 

PDMR Shareholding

Β 

Three of the Company's directors, Alistair McGeorge, Chairman, Colin Henry, NED and Charlie Caminada, NED, have subscribed for a total of 1,282, 380 shares as follows:

Β 

Β 

Β 

Subscription total

Number of new ordinary shares

Total number of new shares to be held on Admission

Alistair McGeorge

Β£ 49,999.95

476,190

476,190

Colin Henry

Β£ 49,999.95

476,190

476,190

Charles Caminada*

Β£ 34,650.00

330,000

330,000

Β 

* Charles Caminada is party to an option agreement with the Company dated 19 July 2021, pursuant to which he has an option to acquire up to 300,000 shares.

Β 

The notifications below, made in accordance with the Market Abuse Regulation, provide further details of the persons discharging managerial responsibilities.

Β 

Year-end update

Β 

East Imperial is pleased to report significant operational and financial progress over the course of 2021, despite the impact of Covid-19 on the Company's on-trade business and more recently the impact from global supply chain problems which have impacted many businesses.

Β 

The Company's 2021 annual revenues were up 60% (based on unaudited figures) compared with the prior year and back at the level achieved in 2019 prior to the impact of COVID-19. Importantly, the Company also benefited from a more diversified revenue stream in 2021 following strong progress implementing a multi-channel strategy.

Β 

The Board is confident of delivering further progress this year, both on-trade and off-trade, and in particular through further geographic expansion in the US and other key markets.

Β 

Tony Burt, CEO of East Imperial, said:

Β 

"I'm extremely pleased with the progress made last year despite the Covid-19 and supply chain challenges and in particular a return to pre-Covid levels of sales reflecting a number of new supply agreements and further global expansion. We have a huge opportunity ahead of us and I'm confident that we will deliver significant further progress this year.

Β 

"I'm also delighted to welcome a number of new investors who share our confidence in the prospects for the business and want to be a part of our success. We will be using the funds raised to capitalise on the near-term opportunities ahead of us, in particular to accelerate our growth in the strategically important US market."

Β 

East Imperial expects to announce its full-year results for the year ended 31 December 2021 in April 2022.

Β 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1. Details of the person discharging managerial responsibilities / person closely associated with them ('PCA')

(a)

Name

Alistair McGeorge

(b)

Reason for the notification

Β 

Notification of person discharging managerial responsibilities (Chairperson of the Board and Non Executive Director of the Company)

(c)

The name of the relevant issuer or emission allowance market participant

East Imperial plc

(d)

A description and the identifier of the financial instrument

Identification code:

Ordinary shares of 1 pence each

Β 

ISIN: GB00BMZ1ND56

(e)

The nature of the transaction(s)

Acquisition of shares pursuant to a placing.

(f)

The date and place of the transaction

Placing letter was executed on 12 January 2022 and shares are due to be admitted to trading on or around 21 January 2022

Outside of a trading venue

(g)

The price and volume of the transaction

Β 

Price

Volume

10.5 pence

476,190

Β 

Β 

2. Details of the person discharging managerial responsibilities / person closely associated with them ('PCA')

(a)

Name

Colin HenryΒ 

(b)

Reason for the notification

Β 

Notification of person discharging managerial responsibilities (Non Executive Director of the Company)

(c)

The name of the relevant issuer or emission allowance market participant

East Imperial plc

(d)

A description and the identifier of the financial instrument

Identification code:

Ordinary shares of 1 pence each

Β 

ISIN: GB00BMZ1ND56

(e)

The nature of the transaction(s)

Acquisition of shares pursuant to a placing.

(f)

The date and place of the transaction

Placing letter was executed on 12 January 2022 and shares are due to be admitted to trading on or around 21 January 2022

Outside of a trading venue

(g)

The price and volume of the transaction

Β 

Price

Volume

10.5 pence

476,190

Β 

Β 

3. Details of the person discharging managerial responsibilities / person closely associated with them ('PCA')

(a)

Name

Charles Caminada

(b)

Reason for the notification

Β 

Notification of person discharging managerial responsibilities (Non Executive Director of the Company)

(c)

The name of the relevant issuer or emission allowance market participant

East Imperial plc

(d)

A description and the identifier of the financial instrument

Identification code:

Ordinary shares of 1pence each

Β 

ISIN: GB00BMZ1ND56

(e)

The nature of the transaction(s)

Acquisition of shares pursuant to a placing.

(f)

The date and place of the transaction

Placing letter was executed on 12 January 2022 and shares are due to be admitted to trading on or around 21 January 2022

Outside of a trading venue

(g)

The price and volume of the transaction

Β 

Price

Volume

10.5 pence

330,000

Β 

Ends

Β 

Enquiries

Β 

Optiva Securities Limited

Robert Emmet +44 (0) 20 3981 4173

Β 

MHP Communications

Peter Hewer +44 (0) 770 9326 261

Rachel Mann +44 (0) 758 5301 464

eastimperial@mhpc.com

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTFIFERLSIVLIF
Date   Source Headline
28th Aug 20242:09 pmRNSResult of GM and Creditors' Meeting
12th Aug 202411:43 amRNSNotice of General Meeting and Creditors' Meeting
31st Jul 20248:49 amRNSCompany update and intention to cancel listing
15th Apr 20247:57 amRNSSuspension of Share Trading
15th Apr 20247:30 amRNSSuspension - East Imperial plc
12th Apr 20244:42 pmRNSCorporate Update
11th Apr 20243:27 pmRNSUpdate re. potential funding sources
11th Apr 20247:00 amRNSResignation of Director
6th Mar 20247:00 amRNSInterview with Chief Executive Officer, Tony Burt
29th Feb 20249:32 amRNSHolding(s) in Company
26th Feb 20247:00 amRNSDirectorsTalk Interview
22nd Feb 20247:00 amRNSYear-End Trading Update
19th Feb 20246:07 pmRNSResult of General Meeting
13th Feb 20247:00 amRNSContinued Global Account Wins in 2024
5th Feb 20247:00 amRNSPartnership with Galaxy Entertainment Group
2nd Feb 202412:19 pmRNSNotice of GM and Capital Reorganisation
2nd Feb 20247:00 amRNSManagement and Board changes
31st Jan 20245:00 pmRNSTotal Voting Rights
31st Jan 20247:00 amRNSHolding(s) in Company
24th Jan 20247:50 amRNSProposed Placing to raise approximately £325,000
3rd Jan 20247:00 amRNSNew Zealand Trading Update
13th Dec 20237:16 amRNSHolding(s) in Company
8th Dec 20237:00 amRNSAppointment of Allenby Capital as Broker
13th Nov 20238:02 amRNSDirectorship Changes
7th Nov 20237:05 amRNSDirectorsTalk Interview
7th Nov 20237:00 amRNSSecond Completion - Secured Convertible Loan Notes
29th Sep 20237:10 amRNSInterim Results
29th Sep 20237:00 amRNSPartnership Agreement
6th Sep 20238:13 amRNSDirectorship Changes
22nd Aug 20237:14 amRNSAppointment of Key US Sales Resource
15th Aug 20237:40 amRNSHolding(s) in Company
14th Aug 202312:54 pmRNSFirst Completion - Secured Convertible Loan Notes
14th Aug 20237:00 amRNSHolding(s) in Company
10th Aug 20238:46 amRNSHolding(s) in Company
4th Aug 202311:18 amRNSResult of General Meeting
28th Jul 20237:00 amRNSAir New Zealand Partnership
19th Jul 202312:25 pmRNSNotice of GM
17th Jul 20237:00 amRNSFunding Update – issue of £2.2m Convertible Loan
30th Jun 202310:13 amRNSResult of AGM
6th Jun 20237:55 amRNSPosting of Annual Report and Notice of AGM
2nd May 20237:00 amRNSAudited Full-Year Results
13th Apr 20237:00 amRNSBoard Change
17th Feb 202310:26 amRNSHolding(s) in Company
9th Feb 20232:05 pmRNSSecond Price Monitoring Extn
9th Feb 20232:00 pmRNSPrice Monitoring Extension
7th Feb 20237:00 amRNSPre-Close Trading Statement
13th Jan 202310:00 amRNSTR-1: Notification of Major Holdings
8th Dec 20227:00 amRNSVietnam Distribution Agreement
24th Nov 20229:06 amRNSSecond Price Monitoring Extn
24th Nov 20229:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.